TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its thin film freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Toronto, Canada.
Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!